PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Clinical Pharmacology, University of Kansas Medical Center, Kansas City, KS, USA. pmoriart@kumc.edu.\', \'Division of Clinical Pharmacology, University of Kansas Medical Center, Kansas City, KS, USA.\', \'Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.\', \'Lipid Clinic, The University of Chicago Pritzker School of Medicine, Chicago, IL, USA.\', \'Division of Cardiovascular Medicine, University of California San Diego, La Jolla, CA, USA. stsimikas@ucsd.edu.\', \'Vascular Medicine Program, Sulpizio Cardiovascular Center, University of California San Diego, 9500 Gilman Drive, BSB 1080, La Jolla, CA, 92093-0682, USA. stsimikas@ucsd.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11883-020-00867-3
?:hasPublicationType
?:journal
  • Current atherosclerosis reports
is ?:pmid of
?:pmid
?:pmid
  • 32710255
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.045
?:rankingScore_hIndex
  • 61
is ?:relation_isRelatedTo_publication of
?:title
  • Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all